NCT01045863 - To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Healthy

Interventions

DRUG

PF-03382792 Cohort 1

First cohort for: Single oral ascending dose of PF-03382792, formulated in solution.

DRUG

PF-03382792 Cohort 2

Second cohort for: Single oral ascending dose of PF-03382792, formulated in solution.

DRUG

PF-03382792

Optional cohort 3: Single oral ascending dose of PF-03382792, formulated in solution.

DRUG

Food Effect cohort

Single oral dose, cross-over to determine effect of food on PF-03382792 pharmacokinetics. Dose will be decided after reviewing data from the ascending dose portion.

DRUG

CSF cohort

Single oral dose of PF-03382792 formulated in solution. Dose will be decided after reviewing data from the ascending dose portion.

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven